These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38008113)

  • 1. Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis.
    Buonfrate D; Montresor A; Bisoffi Z; Tamarozzi F; Bisanzio D
    Philos Trans R Soc Lond B Biol Sci; 2024 Jan; 379(1894):20220433. PubMed ID: 38008113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need.
    Bisanzio D; Montresor A; French M; Reithinger R; Rodari P; Bisoffi Z; Buonfrate D
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009314. PubMed ID: 33857134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control programs for strongyloidiasis in areas of high endemicity: an economic analysis of different approaches.
    Buonfrate D; Zammarchi L; Bisoffi Z; Montresor A; Boccalini S
    Infect Dis Poverty; 2021 May; 10(1):76. PubMed ID: 34030741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side Benefits of Mass Drug Administration for Lymphatic Filariasis on
    Barda B; Albonico M; Buonfrate D; Ame SM; Ali S; Speich B; Keiser J
    Am J Trop Med Hyg; 2017 Sep; 97(3):681-683. PubMed ID: 28722622
    [No Abstract]   [Full Text] [Related]  

  • 6. Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
    Anselmi M; Buonfrate D; Guevara Espinoza A; Prandi R; Marquez M; Gobbo M; Montresor A; Albonico M; Racines Orbe M; Martin Moreira J; Bisoffi Z
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004150. PubMed ID: 26540412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preventive chemotherapy on Strongyloides stercoralis: A systematic review and meta-analysis.
    Stroffolini G; Tamarozzi F; Fittipaldo A; Mazzi C; Le B; Vaz Nery S; Buonfrate D
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011473. PubMed ID: 37428815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Lymphatic Filariasis Mass Drug Administration Scaling Down on Soil-Transmitted Helminth Control in School-Age Children. Present Situation and Expected Impact from 2016 to 2020.
    Mupfasoni D; Montresor A; Mikhailov A; King J
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005202. PubMed ID: 27992424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
    Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Ivermectin Mass Drug Administration for Lymphatic Filariasis on Scabies in Eight Villages in Kongwa District, Tanzania.
    Martin D; Wiegand R; Goodhew B; Lammie P; Mkocha H; Kasubi M
    Am J Trop Med Hyg; 2018 Oct; 99(4):937-939. PubMed ID: 30062986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
    Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
    Anto F; Asoala V; Anyorigiya T; Oduro A; Adjuik M; Akweongo P; Aborigo R; Bimi L; Amankwa J; Hodgson A
    Trop Med Int Health; 2011 Sep; 16(9):1112-9. PubMed ID: 21689221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
    Anagbogu IN; Saka YA; Surakat OA; Okoronkwo C; Davies E; Oyale P; Ekpo UF; Amazigo UV; Barbre K; Igbe M; Nyior A; Jacob SM; Gideon Nteun U; Abubakar Umar Z
    Parasit Vectors; 2022 Jun; 15(1):201. PubMed ID: 35698164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
    Macfarlane CL; Budhathoki SS; Johnson S; Richardson M; Garner P
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003753. PubMed ID: 30620051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
    Kyelem D; Medlock J; Sanou S; Bonkoungou M; Boatin B; Molyneux DH
    Trop Med Int Health; 2005 Oct; 10(10):1002-4. PubMed ID: 16185234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.
    Gandasegui J; Onwuchekwa C; Krolewiecki AJ; Doyle SR; Pullan RL; Enbiale W; Kepha S; Hatherell HA; van Lieshout L; Cambra-Pellejà M; Escola V; Muñoz J
    Lancet Infect Dis; 2022 Nov; 22(11):e341-e347. PubMed ID: 35850127
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.